Holiday Inn

8120 Wisconsin Avenue

Bethesda, Maryland

DRAFT Agenda November 4-5, 2002

8:30 Call to Order and Opening Remarks Robert S. Stern, M.D.
Chair, DODAC

Introduction of Committee

Conflict of Interest Statement Karen M. Templeton-Somers, Ph.D.
Acting Executive Secretary, DODAC

8:45 Open Public Hearing

9:15 Introduction

Jonathan Wilkin, M.D.,
Director, Division of Dermatologic and Dental Drug Products, FDA

9:20 Presentations

10:15 Questions to the Speakers

10:45 Break

11:00 Presentations

12:10 Questions to the Speakers

12:30 Lunch

1:30 Presentations

3:15 Break

3:30 Questions to the Speakers

4:00 Presentations

5:30 Tentative Adjournment for the Day

8:00 Call to Order and Opening Remarks Robert S. Stern, M.D.
Chair, DODAC

Introduction of Committee

Conflict of Interest Statement Karen M. Templeton-Somers, Ph.D.
Acting Executive Secretary, DODAC

8:15 Open Public Hearing

8:45 Committee Discussion

1:00 Tentative Adjournment